These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11964859)

  • 1. Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Marr KA
    Curr Opin Infect Dis; 2001 Aug; 14(4):423-6. PubMed ID: 11964859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Marr KA
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):15-9. PubMed ID: 11757846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
    López-Jiménez J; Duarte-Palomino R; Cabezudo E; Velasco-Martínez JJ; Sousa A; Odriozola J
    Blood; 1997 May; 89(9):3491-2. PubMed ID: 9129061
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
    van Burik JA
    Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of anti-fungal management in lung transplantation.
    Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
    J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
    Paterson PJ; McWhinney PH; Potter M; Kibbler CC; Prentice HG
    Br J Haematol; 2001 Jan; 112(1):175-80. PubMed ID: 11167799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D; Depestel DD; Carver PL
    Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients.
    Bow EJ
    Med Mycol; 2005 May; 43 Suppl 1():S277-87. PubMed ID: 16110821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of fungal infection in transplantation.
    Paya CV
    Transpl Infect Dis; 2002; 4 Suppl 3():46-51. PubMed ID: 12486792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of hematopoietic stem transplantation: Fungal infections.
    Omrani AS; Almaghrabi RS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
    van Burik JH; Leisenring W; Myerson D; Hackman RC; Shulman HM; Sale GE; Bowden RA; McDonald GB
    Medicine (Baltimore); 1998 Jul; 77(4):246-54. PubMed ID: 9715729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
    Bayer AS; Witt MD; Kim E; Ghannoum MA
    Antimicrob Agents Chemother; 1996 Feb; 40(2):494-6. PubMed ID: 8834908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.